{"id":355358,"date":"2026-11-19T14:40:51","date_gmt":"2026-11-19T09:10:51","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=355358"},"modified":"2026-11-19T14:40:51","modified_gmt":"2026-11-19T09:10:51","slug":"hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/","title":{"rendered":"Top Q2 Revenue Growth Stocks Compared: HFCL vs Sterlite Technologies vs SJVN vs Narayana Health vs Aarti Industries on Price, Valuation, Q2 FY27 Results and Risks"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Previous close: HFCL Rs 197.50, Sterlite Technologies Rs 673.15, SJVN Rs 54.64, Narayana Health Rs 1,891.30, Aarti Industries Rs 462.55.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">This Q2 Revenue Growth stocks compared snapshot checks five names on price, valuation and Q2 FY27 results: HFCL, Sterlite Technologies, SJVN, Narayana Health and Aarti Industries. Narayana Health is the largest by market capitalisation at Rs 37,565 crore. Narayana Health reports the highest return on equity at 17.17%. Q2 Revenue Growth names grew for different reasons, so read each multiple next to margins and returns.<\/p>\n<\/p><\/div>\n<p><strong>Q2 Revenue Growth stocks compared<\/strong> here means HFCL, Sterlite Technologies, SJVN, Narayana Health and Aarti Industries on one page, checked on previous close, market value, valuation and the latest quarterly numbers. The group covers two optical fibre and telecom equipment makers, a hydropower developer, a hospital chain and a specialty chemicals maker, which is exactly why a side-by-side look helps.<\/p>\n<p>All five companies have filed their September 2026 quarter, so every result below is Q2 FY27. Q2 Revenue Growth stocks follow new capacity, pricing and demand, so a glance at the <a href=\"https:\/\/univest.in\/indices\/nifty-500\/nifty-500-share-price-today\">Nifty 500<\/a> page and the <a href=\"https:\/\/univest.in\/indices\/sensex\/sensex-share-price-today\">Sensex<\/a> page before you read the tables gives useful backdrop.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=q2-revenue-growth-stocks-compared\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#Q2_Revenue_Growth_Stocks_Compared_Five_Names_on_the_List\" title=\"Q2 Revenue Growth Stocks Compared: Five Names on the List\">Q2 Revenue Growth Stocks Compared: Five Names on the List<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#Q2_Revenue_Growth_Stocks_Valuation_Multiples_Returns_and_Payouts\" title=\"Q2 Revenue Growth Stocks Valuation: Multiples, Returns and Payouts\">Q2 Revenue Growth Stocks Valuation: Multiples, Returns and Payouts<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#Q2_Revenue_Growth_Stocks_Q2_FY27_Results_Revenue_and_Profit_Check\" title=\"Q2 Revenue Growth Stocks Q2 FY27 Results: Revenue and Profit Check\">Q2 Revenue Growth Stocks Q2 FY27 Results: Revenue and Profit Check<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#HFCL_Results_Snapshot\" title=\"HFCL Results Snapshot\">HFCL Results Snapshot<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#Sterlite_Technologies_Results_Snapshot\" title=\"Sterlite Technologies Results Snapshot\">Sterlite Technologies Results Snapshot<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#SJVN_Results_Snapshot\" title=\"SJVN Results Snapshot\">SJVN Results Snapshot<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#Narayana_Health_Results_Snapshot\" title=\"Narayana Health Results Snapshot\">Narayana Health Results Snapshot<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#Aarti_Industries_Results_Snapshot\" title=\"Aarti Industries Results Snapshot\">Aarti Industries Results Snapshot<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#Q2_Revenue_Growth_Stocks_Compared_Two_at_a_Time_Three_Pairings\" title=\"Q2 Revenue Growth Stocks Compared Two at a Time: Three Pairings\">Q2 Revenue Growth Stocks Compared Two at a Time: Three Pairings<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#HFCL_vs_Sterlite_Technologies\" title=\"HFCL vs Sterlite Technologies\">HFCL vs Sterlite Technologies<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#SJVN_vs_Narayana_Health\" title=\"SJVN vs Narayana Health\">SJVN vs Narayana Health<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#Aarti_Industries_vs_HFCL\" title=\"Aarti Industries vs HFCL\">Aarti Industries vs HFCL<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#Best_Q2_Revenue_Growth_Stocks_for_Each_Type_of_Investor\" title=\"Best Q2 Revenue Growth Stocks for Each Type of Investor\">Best Q2 Revenue Growth Stocks for Each Type of Investor<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#What_Is_Driving_Q2_Revenue_Growth_Stocks_Right_Now\" title=\"What Is Driving Q2 Revenue Growth Stocks Right Now?\">What Is Driving Q2 Revenue Growth Stocks Right Now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#Risks_to_Weigh_When_You_Compare_Q2_Revenue_Growth_Stocks\" title=\"Risks to Weigh When You Compare Q2 Revenue Growth Stocks\">Risks to Weigh When You Compare Q2 Revenue Growth Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#How_to_Compare_Q2_Revenue_Growth_Stocks_and_Build_a_Shortlist\" title=\"How to Compare Q2 Revenue Growth Stocks and Build a Shortlist\">How to Compare Q2 Revenue Growth Stocks and Build a Shortlist<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#Conclusion_Q2_Revenue_Growth_Stocks_Compared_at_a_Glance\" title=\"Conclusion: Q2 Revenue Growth Stocks Compared at a Glance\">Conclusion: Q2 Revenue Growth Stocks Compared at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#Frequently_Asked_Questions_on_Q2_Revenue_Growth_Stocks_Compared\" title=\"Frequently Asked Questions on Q2 Revenue Growth Stocks Compared\">Frequently Asked Questions on Q2 Revenue Growth Stocks Compared<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#Which_are_the_top_Q2_Revenue_Growth_stocks_compared_in_this_article\" title=\"Which are the top Q2 Revenue Growth stocks compared in this article?\">Which are the top Q2 Revenue Growth stocks compared in this article?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#Which_Q2_Revenue_Growth_stock_has_the_highest_market_capitalisation\" title=\"Which Q2 Revenue Growth stock has the highest market capitalisation?\">Which Q2 Revenue Growth stock has the highest market capitalisation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#Which_of_these_Q2_Revenue_Growth_stocks_has_the_lowest_price_to_earnings_ratio\" title=\"Which of these Q2 Revenue Growth stocks has the lowest price to earnings ratio?\">Which of these Q2 Revenue Growth stocks has the lowest price to earnings ratio?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#Which_Q2_Revenue_Growth_stock_has_the_highest_return_on_equity\" title=\"Which Q2 Revenue Growth stock has the highest return on equity?\">Which Q2 Revenue Growth stock has the highest return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#How_did_Q2_Revenue_Growth_stocks_perform_in_Q2_FY27_results\" title=\"How did Q2 Revenue Growth stocks perform in Q2 FY27 results?\">How did Q2 Revenue Growth stocks perform in Q2 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#What_are_the_main_risks_when_you_compare_Q2_Revenue_Growth_stocks\" title=\"What are the main risks when you compare Q2 Revenue Growth stocks?\">What are the main risks when you compare Q2 Revenue Growth stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#Which_metrics_matter_most_when_you_compare_Q2_Revenue_Growth_stocks\" title=\"Which metrics matter most when you compare Q2 Revenue Growth stocks?\">Which metrics matter most when you compare Q2 Revenue Growth stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/hfcl-vs-sterlite-technologies-vs-sjvn-vs-narayana-health-vs-aarti-industries-q2-revenue-growth-stocks\/#Which_is_the_best_Q2_Revenue_Growth_stock_to_buy_among_these_five\" title=\"Which is the best Q2 Revenue Growth stock to buy among these five?\">Which is the best Q2 Revenue Growth stock to buy among these five?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Q2_Revenue_Growth_Stocks_Compared_Five_Names_on_the_List\"><\/span><strong>Q2 Revenue Growth Stocks Compared: Five Names on the List<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Q2 Revenue Growth stocks compared here are HFCL, Sterlite Technologies, SJVN, Narayana Health and Aarti Industries. Narayana Health is the largest by <strong>market capitalisation<\/strong> at Rs 37,565 crore. Previous closes run from Rs 54.64 for SJVN to Rs 1,891.30 for Narayana Health, which is why a side-by-side look at value rather than price is more useful. This <strong>Q2 Revenue Growth stocks compared<\/strong> list is the base for every table that follows.<\/p>\n<table>\n<thead>\n<tr>\n<th>Stock<\/th>\n<th>Previous close (Rs)<\/th>\n<th>Market cap (Rs crore)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/hfcl\/hfcl-ltd-share-price-today\">HFCL<\/a><\/td>\n<td>197.50<\/td>\n<td>31,385<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/stltech\/sterlite-technologies-ltd-share-price-today\">Sterlite Technologies<\/a><\/td>\n<td>673.15<\/td>\n<td>36,584<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/sjvn\/sjvn-ltd-share-price-today\">SJVN<\/a><\/td>\n<td>54.64<\/td>\n<td>22,537<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/nh\/narayana-hrudayalaya-ltd-share-price-today\">Narayana Health<\/a><\/td>\n<td>1,891.30<\/td>\n<td>37,565<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/aartiind\/aarti-industries-ltd-share-price-today\">Aarti Industries<\/a><\/td>\n<td>462.55<\/td>\n<td>17,203<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>A quick look at the business behind each ticker puts the numbers in context. HFCL makes optical fibre cables and telecom equipment, while Sterlite Technologies makes optical fibre and digital network products. SJVN builds and runs hydro and solar power projects, and Narayana Health runs a network of multi-speciality hospitals. To compare Q2 Revenue Growth stocks properly, line up <strong>price to earnings<\/strong>, <strong>return on equity<\/strong> and operating margin before forming a view.<\/p>\n<p>Rounding out the group, Aarti Industries makes specialty chemicals and intermediates. A fair Q2 Revenue Growth stock comparison looks at what each company actually earns from, not only at the share price. <strong>A supplier and a services name belong in separate mental boxes whenever you compare Q2 Revenue Growth stocks fairly.<\/strong><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Q2_Revenue_Growth_Stocks_Valuation_Multiples_Returns_and_Payouts\"><\/span><strong>Q2 Revenue Growth Stocks Valuation: Multiples, Returns and Payouts<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>SJVN trades at the lowest <strong>price to earnings<\/strong> ratio in this group at 22.76. Narayana Health reports the highest <strong>return on equity<\/strong> at 17.17%. SJVN has the lowest <strong>price to book<\/strong> value at 1.50. These <strong>Q2 Revenue Growth stocks valuation<\/strong> readings come from the previous close and the latest reported financials. That is the idea behind this <strong>Q2 Revenue Growth stocks compared<\/strong> table: <strong>price to earnings<\/strong> and <strong>return on equity<\/strong> sit side by side so a high or low reading stands out at once.<\/p>\n<table>\n<thead>\n<tr>\n<th>Stock<\/th>\n<th>Price to earnings<\/th>\n<th>Price to book<\/th>\n<th>ROE (%)<\/th>\n<th>Dividend yield (%)<\/th>\n<th>Debt to equity<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>HFCL<\/td>\n<td>33.89<\/td>\n<td>5.56<\/td>\n<td>15.36<\/td>\n<td>0.10<\/td>\n<td>0.33<\/td>\n<\/tr>\n<tr>\n<td>Sterlite Technologies<\/td>\n<td>48.40<\/td>\n<td>8.05<\/td>\n<td>16.64<\/td>\n<td><\/td>\n<td>0.22<\/td>\n<\/tr>\n<tr>\n<td>SJVN<\/td>\n<td>22.76<\/td>\n<td>1.50<\/td>\n<td>6.60<\/td>\n<td>2.62<\/td>\n<td>2.25<\/td>\n<\/tr>\n<tr>\n<td>Narayana Health<\/td>\n<td>43.72<\/td>\n<td>7.51<\/td>\n<td>17.17<\/td>\n<td>0.24<\/td>\n<td>1.21<\/td>\n<\/tr>\n<tr>\n<td>Aarti Industries<\/td>\n<td>29.01<\/td>\n<td>2.75<\/td>\n<td>9.47<\/td>\n<td>0.21<\/td>\n<td>0.83<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Price to earnings, return on equity, debt to equity and <strong>dividend yield<\/strong> give the clearest picture of valuation, returns and balance sheet room across the five names. <strong>Earnings per share<\/strong> and <strong>book value<\/strong> per share are the building blocks behind price to earnings and <strong>price to book<\/strong>, so a glance at both in each filing is time well spent. A simple Q2 Revenue Growth stock comparison like this one is only as useful as the context behind it, which is why operating margin is worth checking as well.<\/p>\n<p>In this group, price to earnings runs from 22.76 for SJVN to 48.40 for Sterlite Technologies. SJVN offers the highest <strong>dividend yield<\/strong> at 2.62%. Industry price to earnings readings differ by sub-sector: HFCL at 16.96; Sterlite Technologies at 36.81; SJVN at 20.29; Narayana Health at 62.11; Aarti Industries at 33.36. The industry price to earnings is a handy anchor: a stock above it is priced for faster growth, and one below it is priced for steadier earnings. <strong>A well-built Q2 Revenue Growth stock comparison also notes that growth from a lower base can look larger than it is.<\/strong> Run the same Q2 Revenue Growth stock comparison on your own watchlist and the pattern in these numbers will be easier to spot.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Q2_Revenue_Growth_Stocks_Q2_FY27_Results_Revenue_and_Profit_Check\"><\/span><strong>Q2 Revenue Growth Stocks Q2 FY27 Results: Revenue and Profit Check<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>All of the five Q2 Revenue Growth stocks compared have filed Q2 FY27 numbers. Sterlite Technologies posted the fastest revenue growth at 145.0% year on year. Sterlite Technologies showed the sharpest rise in net profit at 12825.0%. Read revenue first and <strong>quarterly profit<\/strong> second, since the two together show how much of the growth reaches shareholders. Treat the Q2 FY27 numbers in this <strong>Q2 Revenue Growth stocks compared<\/strong> review as a snapshot of one quarter, not a verdict on any growth company.<\/p>\n<table>\n<thead>\n<tr>\n<th>Stock<\/th>\n<th>Q2 FY27 revenue (Rs crore)<\/th>\n<th>Q2 FY26 revenue (Rs crore)<\/th>\n<th>Q2 FY27 net profit (Rs crore)<\/th>\n<th>Q2 FY26 net profit (Rs crore)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>HFCL<\/td>\n<td>2,569<\/td>\n<td>1,056<\/td>\n<td>394.2<\/td>\n<td>71.9<\/td>\n<\/tr>\n<tr>\n<td>Sterlite Technologies<\/td>\n<td>2,563<\/td>\n<td>1,046<\/td>\n<td>517.0<\/td>\n<td>4.0<\/td>\n<\/tr>\n<tr>\n<td>SJVN<\/td>\n<td>2,290<\/td>\n<td>1,078<\/td>\n<td>657.7<\/td>\n<td>307.8<\/td>\n<\/tr>\n<tr>\n<td>Narayana Health<\/td>\n<td>2,896<\/td>\n<td>1,668<\/td>\n<td>301.1<\/td>\n<td>258.5<\/td>\n<\/tr>\n<tr>\n<td>Aarti Industries<\/td>\n<td>3,894<\/td>\n<td>2,250<\/td>\n<td>169.0<\/td>\n<td>106.0<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"HFCL_Results_Snapshot\"><\/span><strong>HFCL Results Snapshot<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>HFCL&#8217;s Q2 FY27 top line stood at <strong>Rs 2,569 crore<\/strong>, versus <strong>Rs 1,056 crore<\/strong> in Q2 FY26, a rise of <strong>143.2%<\/strong>. Net profit rose 448.1% to Rs 394.2 crore from Rs 71.9 crore. Operating margin expanded to 25.9% from 19.5% a year ago. <strong>Earnings per share<\/strong> for the quarter rose to Rs 2.36 from Rs 0.47.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Sterlite_Technologies_Results_Snapshot\"><\/span><strong>Sterlite Technologies Results Snapshot<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sterlite Technologies reported Q2 FY27 revenue of <strong>Rs 2,563 crore<\/strong>, compared with <strong>Rs 1,046 crore<\/strong> a year earlier, a rise of <strong>145.0%<\/strong>. Net profit rose 12825.0% to Rs 517.0 crore from Rs 4.0 crore. Operating margin expanded to 33.5% from 13.6% a year ago. <strong>Earnings per share<\/strong> for the quarter rose to Rs 9.36 from Rs 0.08.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"SJVN_Results_Snapshot\"><\/span><strong>SJVN Results Snapshot<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>In the September 2026 quarter, SJVN booked revenue of <strong>Rs 2,290 crore<\/strong> against <strong>Rs 1,078 crore<\/strong> in the same quarter last year, a rise of <strong>112.4%<\/strong>. Net profit rose 113.7% to Rs 657.7 crore from Rs 307.8 crore. Earnings per share for the quarter rose to Rs 1.68 from Rs 0.78.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Narayana_Health_Results_Snapshot\"><\/span><strong>Narayana Health Results Snapshot<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Narayana Health&#8217;s Q2 FY27 top line stood at <strong>Rs 2,896 crore<\/strong>, versus <strong>Rs 1,668 crore<\/strong> in Q2 FY26, a rise of <strong>73.6%<\/strong>. Net profit rose 16.5% to Rs 301.1 crore from Rs 258.5 crore. Earnings per share for the quarter rose to Rs 14.82 from Rs 12.72.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Aarti_Industries_Results_Snapshot\"><\/span><strong>Aarti Industries Results Snapshot<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Aarti Industries reported Q2 FY27 revenue of <strong>Rs 3,894 crore<\/strong>, compared with <strong>Rs 2,250 crore<\/strong> a year earlier, a rise of <strong>73.1%<\/strong>. Net profit rose 59.4% to Rs 169.0 crore from Rs 106.0 crore. Net profit margin improved to 4.3% from 3.7%. Earnings per share for the quarter rose to Rs 4.65 from Rs 2.91.<\/p>\n<p>Capacity, pricing and demand shape revenue growth, so each name needs a look at its own results, so profit can look different from revenue in a single quarter. That is why a Q2 Revenue Growth stock comparison works best when revenue and profit are read together across two or three quarters. Used this way, a <strong>Q2 Revenue Growth stocks compared<\/strong> review becomes a map of the sector rather than a price list. When you compare Q2 Revenue Growth stocks after each result season, track how operating margin changes from one quarter to the next. A Q2 Revenue Growth stock comparison built on one quarter of data is a starting point, and the next set of results will update it.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Q2_Revenue_Growth_Stocks_Compared_Two_at_a_Time_Three_Pairings\"><\/span><strong>Q2 Revenue Growth Stocks Compared Two at a Time: Three Pairings<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Readers rarely want a five-way table and nothing else, so here are three head-to-head reads drawn from the same data. Use them as a quick way to compare Q2 Revenue Growth stocks two at a time.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"HFCL_vs_Sterlite_Technologies\"><\/span><strong>HFCL vs Sterlite Technologies<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>HFCL and Sterlite Technologies both make optical fibre and network products. The two are close in size, with <strong>market capitalisation<\/strong>s of Rs 31,385 crore for HFCL and Rs 36,584 crore for Sterlite Technologies. Sterlite Technologies reports the higher return on equity, at 16.64% against 15.36% for HFCL. In Q2 FY27, Sterlite Technologies grew revenue faster, at 145.0% year on year against 143.2% for HFCL. Two telecom suppliers with different mixes, so read margins next to valuation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"SJVN_vs_Narayana_Health\"><\/span><strong>SJVN vs Narayana Health<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>SJVN sells hydropower, while Narayana Health treats patients. Narayana Health is about 1.7 times the size of SJVN by <strong>market capitalisation<\/strong>, at Rs 37,565 crore against Rs 22,537 crore. On price to earnings, SJVN carries the lower multiple at 22.76 against 43.72 for Narayana Health. Narayana Health reports the higher return on equity, at 17.17% against 6.60% for SJVN. A power developer and a hospital chain follow different drivers, so compare returns first.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Aarti_Industries_vs_HFCL\"><\/span><strong>Aarti Industries vs HFCL<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Aarti Industries sells specialty chemicals, while HFCL sells network equipment. On price to earnings, Aarti Industries carries the lower multiple at 29.01 against 33.89 for HFCL. HFCL reports the higher return on equity, at 15.36% against 9.47% for Aarti Industries. For dividend income, Aarti Industries offers 0.21% against 0.10% at HFCL. Two manufacturers with different customers, so read returns together.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Best_Q2_Revenue_Growth_Stocks_for_Each_Type_of_Investor\"><\/span><strong>Best Q2 Revenue Growth Stocks for Each Type of Investor<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Searching for the <strong>best Q2 Revenue Growth stocks<\/strong> usually means different things to different readers. The table below shows who leads on each measure today, so you can pick the row that matches your goal. Any <strong>Q2 Revenue Growth stocks compared<\/strong> table can mislead if you stop at one row, because each growth company leads on a different measure.<\/p>\n<table>\n<thead>\n<tr>\n<th>If you care most about<\/th>\n<th>Start your research with<\/th>\n<th>The number<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Lowest price to earnings<\/td>\n<td>SJVN<\/td>\n<td>22.76<\/td>\n<\/tr>\n<tr>\n<td>Highest return on equity<\/td>\n<td>Narayana Health<\/td>\n<td>17.17%<\/td>\n<\/tr>\n<tr>\n<td>Highest dividend yield<\/td>\n<td>SJVN<\/td>\n<td>2.62%<\/td>\n<\/tr>\n<tr>\n<td>Lowest price to book value<\/td>\n<td>SJVN<\/td>\n<td>1.50<\/td>\n<\/tr>\n<tr>\n<td>Largest by market capitalisation<\/td>\n<td>Narayana Health<\/td>\n<td>Rs 37,565 crore<\/td>\n<\/tr>\n<tr>\n<td>Fastest Q2 FY27 revenue growth<\/td>\n<td>Sterlite Technologies<\/td>\n<td>145.0%<\/td>\n<\/tr>\n<tr>\n<td>Sharpest Q2 FY27 net profit rise<\/td>\n<td>Sterlite Technologies<\/td>\n<td>12825.0%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>No single name tops every row, which is exactly why a Q2 Revenue Growth stock comparison helps. Margins, returns and valuation point to different companies, so decide what matters most to you before you rank the numbers.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Is_Driving_Q2_Revenue_Growth_Stocks_Right_Now\"><\/span><strong>What Is Driving Q2 Revenue Growth Stocks Right Now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>These companies reported strong year on year revenue growth in the September 2026 quarter, so readers study whether the pace can continue. Knowing what moves capacity additions and demand helps you compare Q2 Revenue Growth stocks with the right questions in mind.<\/p>\n<p>Fast revenue growth can come from new capacity, higher prices or a lower base, so the cause matters as much as the number. A good <strong>Q2 Revenue Growth stocks compared<\/strong> routine therefore tracks revenue growth, margins and quarterly results.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Weigh_When_You_Compare_Q2_Revenue_Growth_Stocks\"><\/span><strong>Risks to Weigh When You Compare Q2 Revenue Growth Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Q2 Revenue Growth stocks depend on demand, input costs, policy and the wider market mood. Valuations differ by company, so read each filing for order, volume and margin commentary before you compare them. Every Q2 Revenue Growth stock comparison has blind spots, and for this group the biggest is capacity additions and demand.<\/p>\n<p>Because revenue growth, margins and quarterly results drive these businesses, the most useful habit is to read the management commentary that comes with every result and note what is expected for the next quarter. Read together, the risk notes and the tables make this <strong>Q2 Revenue Growth stocks compared<\/strong> guide a balanced starting point.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Compare_Q2_Revenue_Growth_Stocks_and_Build_a_Shortlist\"><\/span><strong>How to Compare Q2 Revenue Growth Stocks and Build a Shortlist<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Start by deciding which driver of growth you trust most, because each reads the market differently. Readers who follow revenue growth, margins and quarterly results find the group easier to track. Done step by step, this <strong>Q2 Revenue Growth stocks compared<\/strong> routine becomes repeatable rather than a one-off exercise.<\/p>\n<p>Then check valuation and returns, because the five names rarely trade on the same multiple. A telecom supplier next to a hospital chain shows how the business behind each price changes the numbers. Keep the shortlist of <strong>best Q2 Revenue Growth stocks<\/strong> short enough that you can actually follow each company&#8217;s quarterly results. When you compare Q2 Revenue Growth stocks again after new results, update only the rows that changed instead of starting over.<\/p>\n<p>The Univest stock screener lets you filter Q2 Revenue Growth stocks by market capitalisation, return on equity and price to earnings, and the app keeps live prices a tap away through the trading day. Come back to this <strong>Q2 Revenue Growth stocks compared<\/strong> page after the next set of results to see which numbers have moved.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live Q2 Revenue Growth stock data<\/strong><\/a><\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track these Q2 Revenue Growth stocks live.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_Q2_Revenue_Growth_Stocks_Compared_at_a_Glance\"><\/span><strong>Conclusion: Q2 Revenue Growth Stocks Compared at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This Q2 Revenue Growth stocks compared review on price, valuation and Q2 FY27 results shows that no single name wins every measure. Narayana Health leads on both size and return on equity, though the others bring strengths of their own. Treat the <strong>Q2 Revenue Growth stocks Q2 FY27 results<\/strong> and <strong>Q2 Revenue Growth stocks valuation<\/strong> tables as a research starting point, then check the filings and speak to a SEBI-registered advisor before you invest. If you plan to compare Q2 Revenue Growth stocks again next quarter, the same checklist of price to earnings, return on equity and operating margin will work.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Q2_Revenue_Growth_Stocks_Compared\"><\/span><strong>Frequently Asked Questions on Q2 Revenue Growth Stocks Compared<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_top_Q2_Revenue_Growth_stocks_compared_in_this_article\"><\/span><strong>Which are the top Q2 Revenue Growth stocks compared in this article?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Q2 Revenue Growth stocks compared in this article are HFCL, Sterlite Technologies, SJVN, Narayana Health and Aarti Industries. They are checked on previous close, market capitalisation, price to earnings, price to book, return on equity and the latest quarterly results, which gives you one tidy table to work from before you read any filing in detail.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_Q2_Revenue_Growth_stock_has_the_highest_market_capitalisation\"><\/span><strong>Which Q2 Revenue Growth stock has the highest market capitalisation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Among the five names, Narayana Health has the highest market capitalisation at Rs 37,565 crore. Sterlite Technologies follows at Rs 36,584 crore. Because market capitalisation is simply share price multiplied by shares outstanding, it shifts daily, so confirm the live number before using it.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_these_Q2_Revenue_Growth_stocks_has_the_lowest_price_to_earnings_ratio\"><\/span><strong>Which of these Q2 Revenue Growth stocks has the lowest price to earnings ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> On Q2 Revenue Growth stocks valuation, SJVN has the lowest price to earnings ratio among these Q2 Revenue Growth stocks at 22.76, based on the latest reported earnings. Sterlite Technologies sits at the other end at 48.40. A low multiple can reflect slower growth or higher risk as easily as a bargain, so read it next to growth and margins.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_Q2_Revenue_Growth_stock_has_the_highest_return_on_equity\"><\/span><strong>Which Q2 Revenue Growth stock has the highest return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Narayana Health reports the highest return on equity in this group at 17.17%. The ratio measures profit earned for every rupee of shareholder money, which makes it a quick test of capital efficiency. One year can mislead, so look at several, and remember that borrowing can push the figure up.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Q2_Revenue_Growth_stocks_perform_in_Q2_FY27_results\"><\/span><strong>How did Q2 Revenue Growth stocks perform in Q2 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> All of the five names have filed Q2 FY27 numbers in our data. Sterlite Technologies recorded the fastest revenue growth at 145.0% year on year. Sterlite Technologies showed the sharpest net profit rise at 12825.0%. For Q2 Revenue Growth stocks Q2 FY27 results, each filing on the exchange website carries the full detail behind these figures.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_risks_when_you_compare_Q2_Revenue_Growth_stocks\"><\/span><strong>What are the main risks when you compare Q2 Revenue Growth stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Q2 Revenue Growth stocks depend on demand, input costs, policy and the wider market mood. Valuations differ by company, so read each filing for order, volume and margin commentary before you compare them. Keep an eye on revenue growth, margins and quarterly results.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_metrics_matter_most_when_you_compare_Q2_Revenue_Growth_stocks\"><\/span><strong>Which metrics matter most when you compare Q2 Revenue Growth stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue growth, operating margin, return on equity and price to earnings matter most here. Compare each multiple with the company&#8217;s own growth trend. Read each filing for capacity and demand commentary.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_is_the_best_Q2_Revenue_Growth_stock_to_buy_among_these_five\"><\/span><strong>Which is the best Q2 Revenue Growth stock to buy among these five?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The best Q2 Revenue Growth stock depends on which driver of growth you trust most, because the five names differ on all of these. On the numbers in this article, Narayana Health has the largest market capitalisation as well as the highest return on equity; SJVN has the lowest price to earnings as well as the highest dividend yield. Each name wins on a different row, and this is educational content rather than advice. Build a shortlist from the tables, read the latest filings, and talk to a SEBI-registered advisor, because your own goals and risk appetite decide the right fit.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the top Q2 Revenue Growth stocks compared in this article?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Q2 Revenue Growth stocks compared in this article are HFCL, Sterlite Technologies, SJVN, Narayana Health and Aarti Industries. They are checked on previous close, market capitalisation, price to earnings, price to book, return on equity and the latest quarterly results, which gives you one tidy table to work from before you read any filing in detail.\"}},{\"@type\":\"Question\",\"name\":\"Which Q2 Revenue Growth stock has the highest market capitalisation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Among the five names, Narayana Health has the highest market capitalisation at Rs 37,565 crore. Sterlite Technologies follows at Rs 36,584 crore. Because market capitalisation is simply share price multiplied by shares outstanding, it shifts daily, so confirm the live number before using it.\"}},{\"@type\":\"Question\",\"name\":\"Which of these Q2 Revenue Growth stocks has the lowest price to earnings ratio?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"On Q2 Revenue Growth stocks valuation, SJVN has the lowest price to earnings ratio among these Q2 Revenue Growth stocks at 22.76, based on the latest reported earnings. Sterlite Technologies sits at the other end at 48.40. A low multiple can reflect slower growth or higher risk as easily as a bargain, so read it next to growth and margins.\"}},{\"@type\":\"Question\",\"name\":\"Which Q2 Revenue Growth stock has the highest return on equity?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Narayana Health reports the highest return on equity in this group at 17.17%. The ratio measures profit earned for every rupee of shareholder money, which makes it a quick test of capital efficiency. One year can mislead, so look at several, and remember that borrowing can push the figure up.\"}},{\"@type\":\"Question\",\"name\":\"How did Q2 Revenue Growth stocks perform in Q2 FY27 results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"All of the five names have filed Q2 FY27 numbers in our data. Sterlite Technologies recorded the fastest revenue growth at 145.0% year on year. Sterlite Technologies showed the sharpest net profit rise at 12825.0%. For Q2 Revenue Growth stocks Q2 FY27 results, each filing on the exchange website carries the full detail behind these figures.\"}},{\"@type\":\"Question\",\"name\":\"What are the main risks when you compare Q2 Revenue Growth stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Q2 Revenue Growth stocks depend on demand, input costs, policy and the wider market mood. Valuations differ by company, so read each filing for order, volume and margin commentary before you compare them. Keep an eye on revenue growth, margins and quarterly results.\"}},{\"@type\":\"Question\",\"name\":\"Which metrics matter most when you compare Q2 Revenue Growth stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue growth, operating margin, return on equity and price to earnings matter most here. Compare each multiple with the company's own growth trend. Read each filing for capacity and demand commentary.\"}},{\"@type\":\"Question\",\"name\":\"Which is the best Q2 Revenue Growth stock to buy among these five?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The best Q2 Revenue Growth stock depends on which driver of growth you trust most, because the five names differ on all of these. On the numbers in this article, Narayana Health has the largest market capitalisation as well as the highest return on equity; SJVN has the lowest price to earnings as well as the highest dividend yield. Each name wins on a different row, and this is educational content rather than advice. Build a shortlist from the tables, read the latest filings, and talk to a SEBI-registered advisor, because your own goals and risk appetite decide the right fit.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Compare HFCL, Sterlite Technologies, SJVN, Narayana Health and Aarti Industries on price, valuation and Q2 FY27 results in one place, with the risks to check before you invest.<\/p>\n","protected":false},"author":38,"featured_media":355357,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[26300,26299,26301,26302],"class_list":["post-355358","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-best-q2-revenue-growth-stocks","tag-q2-revenue-growth-stocks-compared","tag-q2-revenue-growth-stocks-q2-fy27-results","tag-q2-revenue-growth-stocks-valuation"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["355357"],"rank_math_title":["Q2 Revenue Growth Stocks: HFCL vs Sterlite vs SJVN vs NH"],"rank_math_description":["Q2 Revenue Growth stocks compared: HFCL vs Sterlite Technologies vs SJVN vs Narayana Health vs Aarti Industries on price, valuation, Q2 FY27 results and risks."],"rank_math_focus_keyword":["Q2 Revenue Growth stocks compared"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/top-q2-revenue-growth-stocks-compared-hfcl-vs-sterlite-technologies-vs-sjvn-vs.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/355358","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=355358"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/355358\/revisions"}],"predecessor-version":[{"id":355359,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/355358\/revisions\/355359"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/355357"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=355358"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=355358"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=355358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}